Works by Lv, Dongqing


Results: 32
    1
    2
    3
    4
    5

    Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.

    Published in:
    BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02865-z
    By:
    • Hu, Xingsheng;
    • Zhang, Shucai;
    • Ma, Zhiyong;
    • Feng, Jifeng;
    • Wu, Lin;
    • Lv, Dongqing;
    • Zhou, Jianying;
    • Zhang, Xiaodong;
    • Liu, Li;
    • Yu, Qitao;
    • Liao, Wangjun;
    • Zhang, Yiping;
    • Wang, Xiang;
    • Cheng, Ying;
    • Niu, Hongrui;
    • Wang, Ziping;
    • Wang, Dong;
    • Huang, Cheng;
    • Liu, Chunling;
    • Zhao, Hui
    Publication type:
    Article
    6
    7
    8
    9
    10

    Fatal Empyema Thoracis Caused by Nocardia otitidiscaviarum.

    Published in:
    Infection & Drug Resistance, 2025, v. 18, p. 669, doi. 10.2147/IDR.S501622
    By:
    • Gu, Qianqian;
    • Zhou, Lingren;
    • Shen, Xiaofei;
    • Xu, Le;
    • Wu, Guixian;
    • Pan, Weijia;
    • Lin, Wenxia;
    • Lv, Dongqing;
    • Lin, Ling;
    • Yan, Shuangquan
    Publication type:
    Article
    11
    12
    13
    14

    Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02087-6
    By:
    • Zhong, Jia;
    • Fei, Kailun;
    • Wu, Lin;
    • Li, Baolan;
    • Wang, Zhijie;
    • Cheng, Ying;
    • Li, Xiaoling;
    • Wang, Xicheng;
    • Han, Liang;
    • Wu, Xiaohong;
    • Fan, Yun;
    • Yu, Yan;
    • Lv, Dongqing;
    • Shi, Jianhua;
    • Huang, Jianjin;
    • Zhou, Shaozhang;
    • Han, Baohui;
    • Sun, Guogui;
    • Guo, Qisen;
    • Ji, Youxin
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS).

    Published in:
    Cancer Communications, 2024, v. 44, n. 9, p. 1005, doi. 10.1002/cac2.12594
    By:
    • Lu, Shun;
    • Dong, Xiaorong;
    • Jian, Hong;
    • Chen, Jianhua;
    • Chen, Gongyan;
    • Sun, Yuping;
    • Ji, Yinghua;
    • Wang, Ziping;
    • Shi, Jianhua;
    • Lu, Junguo;
    • Chen, Shaoshui;
    • Lv, Dongqing;
    • Zhang, Guojun;
    • Liu, Chunling;
    • Li, Juan;
    • Yu, Xinmin;
    • Lin, Zhong;
    • Yu, Zhuang;
    • Wang, Zhehai;
    • Cui, Jiuwei
    Publication type:
    Article
    27
    28
    29
    30
    31
    32